Thioredoxin-interacting protein (TXNIP) was first refined from leukemia cells (HL-60) treated with 1,25-dihydroxyvitamin D3 (vitamin D3) and named vitamin D3-upregulated protein-1 (VDUP1) (Chen and DeLuca, 1994). This evidence concerns the gene TXNIP and leukemia.